|
C9ORF129 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.84349988000088E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.238960E-04 |
| Normal-vs-Stage2 |
4.618500E-03 |
| Normal-vs-Stage3 |
1.65919500361156E-11 |
| Normal-vs-Stage4 |
2.7516988687637E-11 |
| Stage1-vs-Stage2 |
5.376400E-01 |
| Stage1-vs-Stage3 |
2.4503000000009E-05 |
| Stage1-vs-Stage4 |
1.60569999999582E-05 |
| Stage2-vs-Stage3 |
2.718400E-02 |
| Stage2-vs-Stage4 |
9.682300E-03 |
| Stage3-vs-Stage4 |
5.438200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.59550048120616E-10 |
| Normal-vs-AfricanAmerican |
3.155300E-04 |
| Normal-vs-Asian |
9.634000E-01 |
| Caucasian-vs-AfricanAmerican |
9.605600E-01 |
| Caucasian-vs-Asian |
9.551700E-02 |
| AfricanAmerican-vs-Asian |
1.300210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.53423973315148E-12 |
| Normal-vs-Female |
1.642750E-04 |
| Male-vs-Female |
1.138080E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.959500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.55790000000433E-06 |
| Normal-vs-Age(61-80Yrs) |
1.73850045470658E-10 |
| Normal-vs-Age(81-100Yrs) |
7.715500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.980000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.485000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.549400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.507600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.685000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.232000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.751600E-01 |
| Normal-vs-Grade 2 |
2.01580000003254E-06 |
| Normal-vs-Grade 3 |
2.81609999763788E-08 |
| Normal-vs-Grade 4 |
1.65045754840776E-12 |
| Grade 1-vs-Grade 2 |
1.259230E-01 |
| Grade 1-vs-Grade 3 |
6.888100E-02 |
| Grade 1-vs-Grade 4 |
1.375900E-04 |
| Grade 2-vs-Grade 3 |
2.022600E-01 |
| Grade 2-vs-Grade 4 |
3.54719999999809E-05 |
| Grade 3-vs-Grade 4 |
9.618800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.765200E-04 |
| Normal-vs-ccB subtype |
8.75389982724073E-10 |
| ccA subtype-vs-ccB subtype |
1.717990E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.7220999999098E-08 |
| Normal-vs-N1 |
4.061800E-02 |
| N0-vs-N1 |
6.615600E-01 |
|
|
